Mandate

Vinge has advised Autoliv and Veoneer

Vinge has advised Autoliv, Inc. (“Autoliv”) and Veoneer, Inc. (“Veoneer”) in connection with the spin-off and listing of Veoneer on the New York Stock Exchange and Nasdaq Stockholm. First day of regular trading of Veoneer was July 2, 2018.

On December 12, 2017, Autoliv announced that, following the conclusion of a strategic review by the board of directors, it intended to spin-off its Electronics business segment, creating a new, independent publicly traded company called Veoneer, Inc. To implement the spin-off, Autoliv has transferred the Electronics business to Veoneer and its subsidiaries and has distributed 100% of the outstanding shares of common stock of Veoneer on a pro rata basis to existing holders of common shares of Autoliv, including shares represented by Swedish Depository Receipts (“SDRs”). In connection with the spin-off and the listing of shares of Veoneer common stock on the New York Stock Exchange and Veoneer SDRs on Nasdaq Stockholm, Autoliv and Veoneer have prepared a registration statement as well as a Swedish prospectus. The registration statement became effective and the prospectus was approved and registered on June 8, and the first day of regular way trading of Veoneer was July 2, 2018.

Veoneer is a growing technology company, focused on active safety, ADAS, autonomous driving and automotive safety electronics. Veoneer’s purpose is to create trust in mobility.  In 2017, Veoneer (as the Electronics business segment of Autoliv) had a turnover of $2.3 billion. Veoneer currently has around 7,600 associates out of which roughly half are in RD&E. Veoneer’s customers are nearly all the top automotive manufacturers in the world. The market value of Veoneer, Inc. on the first day of trading was approximately SEK 34 billion.

Vinge’s team primarily consisted of Göran Nyström, Dain Hård Nevonen, Malte Hedlund, Sabina Kihlberg and Stephanie Stiernstedt, as well as Albert Wållgren, Helena Håkansson, Lionardo Ojeda and Sara Osman regarding financing issues.

Related

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024

Vinge has advised Embracer Group in connection with a EUR 900 million bridge facility agreement entered into with JP Morgan, BNP Paribas, SEB, Société Générale and Swedbank

Vinge has advised Embracer Group AB (publ) (“Embracer”) and its subsidiary group Asmodee in connection with the entry into of a EUR 900,000,000 financing agreement with JP Morgan, BNP Paribas, SEB, Société Générale and Swedbank and concurrent prepayment of existing Embracer indebtedness.
April 22, 2024

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024